Saturday, July 11, 2026 10:51 PM ET
14 hours ago
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?14 hours ago
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer21 hours ago
AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse1 day ago
Employers aren't expanding coverage of GLP-1 obesity drugs, survey says2 days ago
Jim Cramer says these are the 5 stocks to buy during this market rotation5 days ago
Ebola outbreak harder to contain after USAID, Western aid cuts, experts say5 days ago
Jim Cramer says this former Covid market darling is finally investable again10 days ago
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs10 days ago
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes11 days ago
Cramer says this aerospace stock is significantly undervalued, sees 35% upside11 days ago
Medicare will start covering obesity drugs. Here's what patients should know11 days ago
French biotech stock soars 40% after new data on experimental medicine11 days ago
FDA names first companies chosen for faster review of new manufacturing plants11 days ago
Medicare is about to cover obesity drugs — but many seniors may not know it yet13 days ago
Estrogen patches are hard to find, and it may not be resolved any time soon15 days ago
Chan Zuckerberg Initiative's Biohub to open new rare disease funding round16 days ago
This life sciences stock has a secret weapon, and AI will only make it more valuable17 days ago
Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy17 days ago
UPS to invest $48 million in cold facilities amid GLP-1 boom18 days ago
SNAP restrictions could change what shoppers buy — and food giants are watching21 days ago
U.S. opens tariff probe targeting Germany's drug pricing policies22 days ago
What this biotech's volatile stock price tells you about the weight loss market right now22 days ago
UniQure to seek FDA approval for Huntington's disease gene therapy in reversal22 days ago
Biotech IPO revival faces competition from cash-rich big pharma buyers25 days ago
Centene to offer buyouts to some employees as health insurer cuts costs26 days ago
Drugmakers race to find a place in the next wave of obesity drugs28 days ago
CVS Health executives on reducing healthcare's biggest pain points28 days ago
Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'1 month ago
How screwworm in U.S. cattle herds could re-inflate record beef prices1 month ago
The space race is coming for pharma: Why drug development is heading to orbit1 month ago
Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion1 month ago